Rafferty Asset Management, LLC Regenxbio Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 93,821 shares of RGNX stock, worth $555,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,821
Previous 76,641
22.42%
Holding current value
$555,420
Previous $803,000
9.71%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding RGNX
# of Institutions
191Shares Held
45.4MCall Options Held
184KPut Options Held
56.7K-
Black Rock Inc. New York, NY8.61MShares$51 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$28.4 Million2.9% of portfolio
-
Jpmorgan Chase & CO New York, NY4.14MShares$24.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$17.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.19MShares$12.9 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $256M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...